INTRODUCTION
Intracellular transmission of extracellular signals is mediated in large by several groups of sequentially activated protein kinases, which are collectively known as the mitogen-activated protein kinase (MAPK) cascades. In growth factor signaling, the key elucidated MAPK cascade is the extracellular signal-regulated kinase (ERK, also known as p42/44 MAPK) cascade (reviewed in Ref. 1) , which is initiated by the small GTP-binding protein (sGP) Ras. Upon stimulation, Ras assumes its active, GTP-bound form, and recruits the protein kinase Raf-1 to the plasma membrane where the kinase can be activated (2, 3) . At this stage, the signal dissociates from the plasma membrane via a sequential activation of protein kinases, which are MEK, ERK, p90 RSK , and under some conditions, also glycogen-synthase kinase 3. However, the ERK cascade is not the only link between membranal receptors and their intracellular targets, and in the past years several other ERK-like cascades have been identified (1) . One of the best studied of these cascades is the Jun N-terminal kinase [JNK; also known as stressactivated protein kinase ( SAPK) (4, 5) ] cascade that utilizes a sequential activation of PAK1/MLK, MEKK1, SEK1/MKK7, and JNK1/2 to activate transcription factors such as c-Jun, ATF2, and Elk1 (reviewed in Refs. 6 and 7). Additional MAPK cascades are the p38RK [HOG, CSBP (8) (9) (10) ] and ERK5 [BMK (11) ]. The extent of activation of these different cascades varies according to stimuli, and the ratio between the signals in each cascade may determine signaling specificity. For example, JNK appears to be highly activated by stress, whereas the ERKs are mainly activated by mitogens. Interestingly, MKK4 [SEK1 (12, 13) ] activates both JNK and p38RK, thus indicating the existence of some cross-talk between the cascades in mammalian cells.
GnRH, which is a hypothalamic decapeptide, serves as a key regulator of the reproductive system. It induces the synthesis and release of the pituitary gonadotropin LH and FSH. When GnRH binds to its seven-transmembrane receptor, it induces interaction of the receptor with the heterotrimeric Gq protein that leads to activation of phospholipase C and formation of inositol 1,4,5-trisphosphate and diacylglycerol, leading to elevation of Ca 2ϩ and activation of protein kinase C (PKC). Phospholipase D, phospholipase A 2 , and the formation of bioactive lipoxygenase products are also activated by GnRH, although the mechanisms involved are not yet known (reviewed in Refs. 14 and 15) . Recently, the stimulation of the ERK-signaling cascade by GnRH has been demonstrated by several laboratories (16) (17) (18) (19) . ERK activation in response to GnRH is unique as it was shown to be fully mediated by PKC and Ca 2ϩ , which seem to act in a Ras-independent manner (19) . Furthermore, the protein tyrosine kinase (PTK) inhibitor genistein partially inhibited this pathway, which indicates the involvement of a PTK in the GnRH-induced ERK activation.
In this study, stimulation of the JNK pathway by GnRH was examined. Our results show that GnRHinduced JNK activation was greater but occurred more slowly than that of ERK. The signaling pathway that mediates the GnRH stimulation of JNK appears to involve PKC, c-Src, CDC42/Rac1, and probably also MEKK1, and to act independently of the ERK cascade. Thus, the ␣T3-1 cells appear to utilize a unique pathway that links a G protein-coupled receptor to the activation of the JNK-signaling cascade through PKC, c-Src, and CDC42.
RESULTS

Stimulation of JNK Activity and Jun Expression by GnRH
Recently, we have shown that the activity of ERK1 and ERK2 is stimulated by GnRH in pituitary ␣T3-1 cells (19) . To examine whether GnRH can also activate the JNK pathway, serum-starved ␣T3-1 cells were stimulated with a GnRH analog (GnRH-a, 10 Ϫ7 M), and JNK activity was monitored by a solid phase assay (20) . As shown in Fig. 1 , JNK activity was significantly (25-to 55-fold) stimulated by GnRH-a, to an extent similar to that caused by the potent stimulating agents, peroxovanadate (VOOH, 15 min) and the PKC activator tumor-promoting agent (TPA, 30 min). This magnitude of stimulation was higher than that observed for ERK1/2 (5-to 15-fold) in the same cells. However, the time course of JNK activation by GnRH-a was slower than the rapid activation of the ERKs. JNK activation was detected 5 to 10 min after the initiation of the GnRH-a treatment, it peaked by 30 min, and it decreased over the next 90 min (Fig. 1B) . Thus, although both ERK and JNK might be key mediators of GnRH signaling, they may regulate different cellular processes.
Since activation of the JNK cascade is known to induce c-Jun expression in several cell systems (7), we examined whether c-Jun expression is also induced by GnRH in ␣T3-1 cells. Northern blot analysis, using c-Jun as a probe, revealed that GnRH-a induced the expression of c-Jun mRNA in these pituitary cells (Fig.  1C) , thus confirming the findings of Cesnjaj et al. (21) . Taken together, these results indicate that the JNK cascade does indeed play a role in GnRH signaling in ␣T3-1 cells. 
Effects of PKC and PTK Inhibitors on JNK Activation
Activation of ERKs by GnRH-a requires PKC and to some extent also protein tyrosine phosphorylation (16) (17) (18) (19) . Therefore, the role of PKC and PTKs in GnRHinduced JNK activation was examined. Exposure of ␣T3-1 cells to TPA or to VOOH (general activator of tyrosine kinases) caused a pronounced stimulation of JNK activity (Fig. 1A) , which suggested that PKC and PTK might stimulate JNK activity in this cell line. Whether PKC is indeed involved in GnRH signaling was determined using PKC depletion and inhibition. Thus, ␣T3-1 cells were pretreated with TPA (1 M, 16 h) which depletes most PKC isoforms, or with the selective PKC inhibitor GF109203X. In both cases there was a significant (80-85%) inhibition of the GnRH-induced JNK activity ( Fig. 2A) . These results suggest that, as in the case of ERK (19) , activation of JNK by GnRH-a in these cells is mainly mediated by PKC.
To determine whether PTKs are involved in the GnRH-induced activation of JNK, we pretreated the ␣T3-1 cells with the PTK inhibitor, genistein. Genistein completely abolished the GnRH-stimulated JNK activity for up to 1 h after stimulation (Fig. 2B ) but only inhibited ERK activation by ϳ30% (19) , indicating the existence of a genistein-sensitive PTK that mediates the activation of JNK by GnRH-a. To determine whether this PTK is located upstream or downstream to PKC, genistein-treated ␣T3-1 cells were stimulated with TPA. As shown in Fig. 2 , C and D (that quantitate the results of panels A-C), stimulation of JNK activity by TPA was most prominent after 60 min (ϳ30-fold), and this stimulation was completely abolished by pretreatment with genistein. TPA bypasses the GnRH receptor-Gq complex and activates PKC directly; these results indicate that PKC is located upstream to the PTK(s) in the pathway that mediates the activation of JNK by GnRH. Sequential activation of PKC and PTKs that leads to JNK activation in G-protein coupled receptors signaling seems to be unique to GnRHstimulated ␣T3-1 cells, as will be discussed below.
c-Src Is Involved in the GnRH-JNK Signaling Pathway
The involvement of a putative PTK that was implicated by the use of genistein initiated an effort to identify the PTK that is involved in JNK activation by GnRH. c-Src or other member(s) of the Src family of PTKs are genistein-sensitive protein kinases that have been previously reported to participate in G-protein signaling (22) (23) (24) . To examine whether a c-Src family member is the PTK that mediates the effect of GnRH on JNK, we first asked whether these kinases are expressed in the ␣T3-1 cells. Western blot analysis revealed that the ␣T3-1 cells contain a substantial amount of c-Src, a small amount of Fyn, and, as expected, no Lyn (Fig.  3A) . Activation of c-Src by GnRH-a was probed by immunoprecipitating c-Src from GnRH-a-stimulated cells using specific antibodies and measuring its activity using enolase as a substrate (25) . GnRH-a caused an ϳ3.2-fold increase in c-Src activity, which peaked at 5 min after stimulation and was maintained for an additional 15 min (Fig. 3, B and C) . Although the , and C by an imaging densitometer. F, GnRH-a; f, GnRH-aϩ TPA depletion; OE, GnRH-aϩGF109203X; x, GnRH-aϩgenistein; , TPA; ࡗ, TPA ϩ genistein. All results are from a representative experiment that was reproduced three times.
fold activation seems to be small, it is comparable to the activation reported in other cellular systems (22) and might be due to a high basal activity of this PTK. c-Src was activated also by TPA (2.6-fold; Fig. 3 , B and C), and the activation of c-Src by GnRH was sensitive both to PKC and to PTK inhibitors, thus indicating that the activation of c-Src in response to GnRH-a is downstream of PKC.
The involvement of c-Src in GnRH-induced JNK activation was then examined by cotransfecting Csk, which serves as a Src-dominant interfering kinase (22) , together with hemagglutinin (HA)-JNK2 into the ␣T3-1 cells. GnRH-stimulated JNK activity was markedly inhibited by the overexpression of Csk, whereas the basal activity of JNK was not affected (Fig. 4A) , indicating that most, if not all, the GnRH signal toward JNK is indeed mediated by c-Src. To further verify this point we also cotransfected the constitutively active form of c-Src, Y527F-Src, together with HA-JNK2 into the same cells. Y527F-Src by itself activated JNK up to 4-fold above basal activity, and this activity was not enhanced by the addition of GnRH-a to the cells (Fig.  4 , B and C), further indicating that most of the GnRH signal is funneled through c-Src. Moreover, the activation of JNK by Y527F-Src was sensitive to genistein (Fig. 4 , B and C), indicating that c-Src by itself is a target for genistein and therefore might be the genistein-sensitive PTK in the GnRH-JNK pathway. As expected, GF109203X did not influence the Y527F-Src activation of JNK (up to 60 min treatment with the inhibitor). Therefore, GnRH signal toward JNK appears to be mediated mainly via the genistein-sensitive c-Src (or a family member), operating downstream of PKC.
JNK Stimulation by GnRH Is Mediated by CDC42/ Rac1 but Not Ras
The JNK signaling cascade is known to act downstream of several sGPs, such as Rac1, CDC42, and Ras (26, 27) . Therefore, we examined which, if any, of the sGPs is involved in the GnRH-stimulated, genistein-sensitive, JNK activation. Thus, the dominant interfering mutants of three sGPs (T17N-Rac2, T17N-CDC42, and S17N-H-Ras) were cotransfected into ␣T3-1 cells together with HA-JNK2. After cell treatment with the desired stimuli and inhibitors, lysis of the cells and immunoprecipitation with anti-HA antibodies, JNK2 activity was measured using GST-Jun as a substrate. All three inactive forms of the sGP had an inhibitory effect on the GnRH-stimulated JNK2 activity (Fig. 5, A and B) . T17N-CDC42 inhibited GnRHstimulated JNK activity by as much as 62 Ϯ 5%, the T17N-Rac1 by 36 Ϯ 4%, and the S17N-H-Ras by only 17 Ϯ 4%.
Since the inhibition of GnRH stimulation of JNK activity by the dominant interfering forms of the sGPs was incomplete, some of the GnRH-induced, genistein-sensitive signaling may have been mediated by an sGP-independent pathway. To test this possibility, constitutively active forms of the same sGPs (Q61L-CDC42, Q61L-Rac1, and Q61L-H-Ras) were cotransfected into ␣T3-1 cells together with HA-JNK2, and the stimulation of JNK activity was determined as above. The constitutively active CDC42 stimulated JNK activity greatly [8.8 Ϯ 1.3 fold (n ϭ 3), which is 65% of GnRH stimulated JNK activity under these conditions]. The constitutively active form of Rac1 had a moderate effect (3.8 Ϯ 0.5 fold), and the constitu- A, Western blot analysis of Src family members in ␣T3-1 cells. Total cell extracts were separated by SDS-PAGE and subjected to Western blotting using anti-Src, anti-Fyn, and Anti-Lyn anti-peptide antibodies (Santa Cruz, according to the manufacturer instruction and using alkaline phosphatasecoupled secondary antibody). To assure the specificity of the antibodies, the antigenic peptide was used (100 g/ml) for competition. B, c-Src activation by GnRH-a and TPA: ␣T3-1 cells were treated with GnRH-a (10 Ϫ7 M) for the indicated times, or pretreated with GF109203X (3 M, 15 min) and with genistein (200 M, 15 min) and then treated with GnRH-a (top panel). Alternatively, the cells were stimulated with 200 nM TPA (lower panel) Stimulation was terminated by washing with ice-cold PBS followed by c-Src immunoprecipitation. c-Src activity toward acid-denatured enolase was determined as described in Materials and Methods. C, Quantification of the results in panel B. The reactions were analyzed by an SDS-PAGE, and the amount of phosphate incorporated into enolase was determined by imaging densitometer. These results are an average of two experiments. F, GnRH-a activation of Src; f, GnRH-a ϩ GF109203X; OE, GnRH-a ϩ genistein. Inset, TPA stimulation.
tively active H-Ras had only a marginal effect (1.9 Ϯ 0.7 fold; Fig. 5C ). The stimulation of HA-JNK2 by Q61L-CDC42 or by Q61L-Rac1 was not affected by the PKC inhibitor GF109203X nor by the PTK inhibitor genistein (Fig. 5C ). In addition, TPA stimulation of JNK activity was significantly inhibited by the T17N-CDC42 (Fig. 5D) , which supports CDC42 and also, to a lesser extent, Rac1 acting downstream of PKC and c-Src. The effects of the PKC and PTK inhibitors on cells cotransfected with the constitutively active form of H-Ras could not be determined because of the low stimulation with this construct.
The above results indicate that most of the genistein-sensitive, GnRH-induced JNK activation is mediated by CDC42. Although in many cases CDC42 and Rac1 seem to use similar guanine nucleotide exchange factors, the effect of Rac1 on the GnRH-JNK pathway seems to be limited. Similar phenomenon, where CDC42 transmits downstream signals without the involvement of Rac1, was recently reported for serum-induced proliferation (28) . Ha-Ras does not seem to be significantly involved in GnRH-induced signaling that contributes to the JNK cascade.
GnRH Stimulation of JNK Is Mediated by MEKK1 But Not by MEK1
Several reports have recently suggested that the stress-activated JNK cascade consists of JNK, JNKK (SEK1, MKK7), MEKK1 (6), and either PAK1 (29) or MLK (30) . To determine whether the genistein-sensitive GnRH signal toward JNK is mediated via this cascade, ␣T3-1 cells were cotransfected with HA tagged-JNK2 and the truncated, constitutively active form of MEKK1 (31) and processed as described for the sGPs above. The constitutively active MEKK1 elicited a strong activation (ϳ25 fold) of JNK2, which was somewhat lower than the activation caused by GnRH-a (data not shown) but could not be further activated by treatment of the transfected cells with GnRH-a (Fig. 6) . The lack of synergistic activation with MEKK1 and GnRH indicates (although does not prove) that MEKK1 might be involved in the GnRH-JNK signaling pathway. Indeed, the MEKK1 effect was not blocked by GF109203X or genistein when added for 15 ( Fig. 6) , 60, or 120 min (data not shown), thus indicating that PKC and the genistein-sensitive PTK(s) are probably situated upstream of MEKK1, (although they may lie on a distinct pathway in case MEKK1 is not the activatory component as suggested above). On the other hand, coexpression of HA-JNK2 with the constitutively active form of MEK1 [⌬N-EE-MEK (32, 33) ] which is involved in the distinct ERK signaling cascade, did not affect JNK activity under conditions in which MEKK1 caused its strong activations (data not shown). This later observation is in agreement with our previous findings on the effects of ⌬N-EE-MEK in COS7 cells (32) . Thus, in ␣T3-1 and COS7 cells, but unlike in U937 cells (34) , the JNK signaling cascade appears to be completely distinct from the MEK-ERK cascade.
Taken together, our results support a model wherein GnRH-stimulated JNK activation is mediated by a pathway involving PKC, c-Src, CDC42/Rac1, and possibly MEKK1, which might lead to the expression of Jun detected upon GnRH stimulation of the ␣T3-1 cells. A divergence of the GnRH-stimulated ERK and JNK pathways at the level of PKC stimulation of PTK activity was suggested by the differential sensitivity of the two MAPKs to genistein (Fig. 7) .
DISCUSSION
Binding of GnRH to its membranal receptor elicits a series of signaling pathways (14) , including activation of the ERK cascade (16) (17) (18) (19) . However, the ERK cascade is not the only route by which GnRH communicates with the nucleus. Here the JNK pathway is shown to be significantly activated in response to GnRH-a, to a much greater extent than the ERK cascade. The time course of this GnRH-induced JNK activation in response to GnRH-a is slower than that of ERK (Fig. 1B) and is similar to time courses observed for the induction of JNK by other heterotrimeric G protein-coupled receptors (35) and tyrosine kinase receptors (36) . However, this slower time course does not occur in all cells. For example, in nerve growth factor-treated PC12 cells, the short-term JNK activation is rapid (10-30 min) and transient (37) . Thus, like the ERK pathway (38) , the duration of JNK activity may determine the outcome and specificity of the signal. The delayed response of JNK observed here (Fig. 1 ) may indicate that JNK is involved in a later stage of transcription regulation and suggests that the signaling machinery that is involved in the activation of JNK is different from that leading to ERK activation. This upstream machinery was elucidated in this study, and our results suggest that GnRH binding to its receptors triggers the activation of PKC, which occurs most probably via the heterotrimeric Gq protein and PLC. The signal is then transmitted to a Src-family PTK and further to the sGPs CDC42 and possibly Rac1. The sGPs activate, in turn, a sGP-activated kinase whose identity is still controversial and which might be PAK1 (29) , MLK (30), or another unknown protein kinase. Finally, the JNK cascade, including JNKKK (probably MEKK1), JNKK, and JNK (reviewed in Ref. 6 ), is activated, causing the stimulation of several transcription factors including, most likely, c-Jun (6) and the expression of c-Jun protein (Fig. 7) .
It is well established by now that PKC mediates many of the downstream effects of GnRH, including the activation of the ERK cascade (14) . In ␣T3-1 cells, JNK activation, like that of ERK (19) , is activated by TPA and markedly inhibited (80-85%) by the PKCspecific inhibitor GF109203X or by TPA depletion of PKC (Fig. 2) . This degree of activation would imply that most of the GnRH signal toward JNK is mediated by PKC, although the small amount of residual activity upon PKC inhibition could suggest an additional signaling machinery. This involvement of PKC in JNK activation by GnRH seems to be unique to our system. In other cell lines TPA does not stimulate JNK activity (35, 39, 40) or may even cause a decrease in the basal activity of JNK (32) . A clue regarding the identity of the putative components of GnRH signaling was first achieved by the effect of PTK inhibitors on JNK activity. Thus, the PTK inhibitor, genistein, completely blocked GnRH-stimulated JNK activation (Fig. 2) whereas it inhibited only ϳ30% of ERK activation by GnRH (19) . Moreover, TPA-induced JNK activation was also blocked by genistein (Fig. 2) , indicating that the PTK is located downstream to PKC. Since TPA bypasses the GnRH receptor-Gq complex and activates PKC directly, our results indicate that the PKC-PTK step is located in the pathway leading to GnRH activation of JNK. This is reminiscent of the involvement of PTKs in PKC signaling toward ERK in other systems (19, 41, 42) . The difference in the extent of inhibition by genistein suggests that two (or more) distinct PTKs may be involved in the activation of ERK and JNK by GnRH. Therefore, the activation of PTKs by PKC might be the point of divergence between the JNK and ERK cascades in ␣T3-1 cells (Fig. 7) .
Recently, Src family protein kinases have been implicated in some G protein-coupled receptor signaling pathways. Lyn is involved in the activation of MEK in DT40 cells (23) , and c-Src is involved in Angiotensin II signaling in COS cells (43) . Our results showing that c-Src is involved in the stimulation of JNK activity (Figs. 3 and 4) in a GF109203X-independent, but genistein-dependent, manner implies that c-Src (or a member of its family) is the PTK that mediates PKCdependent signaling toward JNK. Since JNK activation by GnRH-a was completely blocked by a Srcdominant interfering kinase (Csk), and JNK could not be further activated by GnRH in cells transfected with the constitutively active form of c-Src, this PTK seems to act as a central component that funnels all the PKC-mediated GnRH signals toward JNK. The mechanism by which PKC induces c-Src activation in the GnRH-JNK system is not clear. PKC has already been shown to directly activate c-Src by phosphorylation of its serines 12 and 48 (44) , which are required for the enhanced response to ␤-adrenergic agonists in cells overexpressing c-Src. The importance of the c-Src phosphorylation on serine 12 was supported also by Liebenhoff et al. (45) , who suggested that this phosphorylation by PKC induces cytoskeletal association necessary for c-Src activation. Furthermore, G protein-coupled receptors may mediate their signal through a cascade of PTK that involves activation of c-Src by Pyk2 (22) or c-Src and FAK (46) . Therefore, in the GnRH-JNK pathway studied here, PKC may activate an upstream PTK, which in turn activates c-Src. However, since some reports have implied that PKC may be located downstream of c-Src in the signaling pathway leading to proliferation (47, 48) , the relationship between PKC and c-Src is not yet fully understood, and some other signaling components may be involved in the activation of c-Src by PKC. The activation of JNK involves in most cases the sGPs, CDC42 and Rac1, that might operate downstream to Ras (26, 27) . Both dominant-negative and constitutively active forms of these G proteins were used to determine whether they participate in the genistein-sensitive GnRH-stimulated pathway leading to JNK activation. Here we show that CDC42 and, to some extent, also Rac1 are involved in this activation, whereas the involvement of Ras is unlikely (Fig. 5) . The activation of Rac1 and CDC42 by stress-activated signals was previously shown to be Ras-dependent (27) . Therefore, the activation of JNK by GnRH in ␣T3-1 cells seems to differ and involves a Ras-independent activation of Rac1 and CDC42 by c-Src. Although the mechanism of activation is not yet known, it might involve a distinct set of adaptor molecules and nucleotide exchange factors.
In summary, we demonstrated here the activation of the JNK cascade by a unique signaling pathway that involves PKC, c-Src family PTK, CDC42/Rac1, and probably MEKK1, which leads to JNK activation and most likely to the c-Jun induction in response to GnRH. Similar to the ERK cascade, the activation of JNK by GnRH is PKC dependent, and the point of divergence between the two cascades seems to be the activation of PTK downstream of PKC. Furthermore, the JNK pathway in these cells seems to be different from most other signaling pathways that link G protein-coupled receptors to the activation of JNK in that it includes the activation of CDC42/Rac1 by PKC and c-Src in a Ras-independent mechanism.
MATERIALS AND METHODS
Buffers
Homogenization buffer (buffer H) consisted of 50 mM ␤-glycerophosphate (pH 7.3), 1.5 mM EGTA, 1 mM EDTA, 1 mM dithiothreitol, 0.1 mM sodium orthovanadate, 1 mM benzamidine, aprotinin (10 g/ml), leupeptin (10 g/ml), and pepstatin (2 g/ml). HEPES lysis buffer consisted of 20 mM HEPES (pH 7.6), 10 mM EGTA, 40 mM ␤-glycerophosphate, 1% Nonidet P-40, 2.5 mM MgCl 2 , 1 mM dithiothreitol, 2 mM sodium orthovanadate, aprotinin (20 g/ml), leupeptin (20 g/ml), and 1 mM phenylmethylsulfonyl fluoride. The JNK buffer consisted of 20 mM HEPES (pH 7.6), 20 mM MgCl 2 , 40 mM ␤-glycerophosphate, 0.1 mM sodium orthovanadate, and 2 mM dithiotritol. The PTK buffer consisted of 50 mM HEPES (pH 7.6), 150 mM NaCl, 5 mM MnCl 2 , 5 mM MgCl 2 , 0.1 mM sodium orthovanadate, and 1 mM dithiothreitol.
Stimulants, Inhibitors, Antibodies, and Miscellaneous Reagents
[D-Trp 6 ]-GnRH, a stable GnRH analog, genistein (PTK inhibitor), enolase, and protein A-Sepharose were obtained from Sigma Chemical Co. (St. Louis, Mo). GF109203X (a PKC inhibitor) and TPA were purchased from Calbiochem (La Jolla, CA). GST-Jun (1-97) was prepared as previously described (20) . Mouse monoclonal antihemagglutinin (HA)-antibodies were produced by the Antibody Unit of The Weizmann Institute of Science. Rabbit polyclonal anti-c-Src antibodies, N-16 and SRC 2, and anti-Fyn and anti-Lyn antibodies and their control peptides were purchased from Santa Cruz (San Diego, CA). Mouse monoclonal anti-active MAPK antibodies were from Sigma (Rehovot, Israel).
Plasmids
The CDC42 constructs (Q61L and T17N-CDC42) were a gift from Dr. G. Bokoch (The Scripps Research Institute, La Jolla CA). The Csk construct was a gift from Dr. S. Courtneidge (Sugen, Inc. Redwood City, CA). MEKK1, GST-c-Jun JNK2, and Rac constructs were provided by Dr. Y. Ben-Neriah (Hebrew University, Jerusalem, Israel). ⌬N-EE-MEK was cloned in pCDNA1 (Invitrogen, San Diego, CA) as previously described (32) .
Solid Phase Assay for JNK Activity
Pituitary ␣T3-1 cells were grown to 80% confluency serum starved for 16 h, and the examined stimulants were added for various time intervals. The cells were then washed (twice with PBS and once with buffer H), scraped into 250 l of buffer H and sonicated (50 W, 2 ϫ7 sec), all at 4 C. After centrifugation (20,000 ϫ g, 15 min, 4 C), aliquots of the resulting supernatant were assayed by the Coomassie protein assay (Pierce, Rockford, IL) for protein. JNK activity was detected according to Hibi et al. (20) . Briefly, aliquots (100-150 g protein) of the cell extracts were incubated (2 h, 4 C) with GST-Jun to allow the JNKs to bind to the substrate. After extensive washing, the JNK activity was measured by phosphorylation of the GST-Jun, which was mediated by the bound kinase in the presence of 20 mM MgCl 2 , 20 M [␥-32 P]-ATP (300 cpm/ pmol) for 20 min at 30 C. The reactions were terminated by the addition of sample buffer, and the samples were subjected to SDS-PAGE analysis. The gels were dried, autoradiographed on Kodak X-100 films, and the phosphorylation of GST-Jun was quantitated by densitometry (Bio-Rad 690 densitometer, Bio-Rad, Richmond, CA).
Transfection of ␣T3-1 Cells
Subconfluent ␣T3-1 cells were cotransfected with 5 g each of HA-JNK2-SR␣ and one of the following plasmids (MEKK-pCMV5, Q61L-Rac1-pCDNA3, T17N-Rac1-pCDNA3, Q61L-CDC42-pCDNA3, T17N-CDC42-pCDNA3, Q61L-HRas-pCMV5, S17N-H-Ras-pCMV5, Y527F-Src-RK5, and Csk-pRK5) using the calcium phosphate technique (49) . The total amount of plasmid was adjusted to 10 g with vector DNA in the control experiments. The transfection efficiency was 10-30%, as determined by transfection with a plasmid that contained ␤-Gal and appropriate staining. Two days after transfection, the cells were serum starved for 16 h and incubated for the desired time intervals with GnRH-a in the presence or absence of various inhibitors. The cells were then lysed with 250 l of HEPES lysis buffer at 4 C, vortexed, and kept on ice for 5 min. After centrifugation (20,000 ϫ g, 20 min), the supernatant was assayed for protein content as above.
Immunoprecipitation with Anti-HA Antibodies
Lysates from transfected cells (400-500 g protein in HEPES lysis buffer) were incubated (1 h, 4 C) with anti HA-antibodies (3 g Ab/reaction). The immunocomplexes were precipitated with Protein A-Sepharose, and the resulting precipitates were washed twice with PBS containing 1% Nonidet P-40 and 2 mM sodium vanadate, once with 100 mM Tris (pH 7.5) containing 0.5 M LiCl and once with JNK buffer. The immunoprecipitates were then resuspended in 30 l of JNK buffer, and the JNK activity was measured (30 min, 30 C with constant mixing) using GST-c-Jun as a substrate. Phosphorylation of GST-c-Jun was monitored by autoradiography.
Immunoprecipitation with Anti c-Src Antibodies
Cell lysates (400-500 g protein in HEPES lysis buffer) were incubated (1 h at 4 C) with anti-c-Src-antibodies (5 g/reaction) and then precipitated with Protein A-Sepharose. The immunocomplexes were washed twice with PBS containing 1% Nonidet P-40 and 2 mM sodium vanadate, once with 100 mM Tris (pH 7.5) containing 0.5 M LiCl, and once with PTK buffer. The washed immunoprecipitates were resuspended in PTK buffer and the c-Src activity was determined by using acid-denatured enolase (3 mM) as substrate (final volume of 40 l) in the presence of 20 M [␥ 32 P]-ATP (8,000 cpm/pmol). The enzymatic reactions were terminated by the addition of sample buffer. The samples were then subjected to SDS-PAGE, autoradiography, and densitometry analysis.
RNA Extraction and Northern Blot Analysis
Total RNA was isolated from cells by extraction in guanidium thiocyanate containing 8% ␤-mercaptoethanol by the LiCl method. For Northern blot analysis, total RNA (15 g) was fractionated on 1.2% denaturing agarose gel and transferred to GeneScreen membrane (Dupont, NEN, Boston, MA). After baking and prehybridization, the membranes were hybridized (16 h) with the specifc cDNA probes labeled to high specific activity using a random primer labeling kit (Boehringer Mannheim, Indianapolis, IN). The filters were washed at high stringency and autoradiographed.
